Researchers examined the generational differences across the population of the UK in risk perceptions, emotions, and beliefs about climate change and climate engagement.
Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO
→ Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was the CEO of Metacrine,